patent expiry

News

MSD splits pharma business, hiving off oncology

MSD is separating its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31bn blockbuster Keytruda.

News

Novartis sheds staff as Entresto patent expiry looms

Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto.

News

an older man's hand with a pill in his palm

FDA approves first generics of anticoagulant Xarelto

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto.

News

BMS extends its cost-cutting drive by another $2bn

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2200 job cuts, adding a target of another $2bn by end-2027.

News

Novartis less exposed to US pricing pressure, says Jimenez

Europe and Asia account for a large share of company's income.

MSD splits pharma business, hiving off oncology

Novartis sheds staff as Entresto patent expiry looms

FDA approves first generics of anticoagulant Xarelto

BMS extends its cost-cutting drive by another $2bn

Novartis less exposed to US pricing pressure, says Jimenez

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

patent expiry

Editor's Picks